KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Q3 2025 value amounting to $1.6 million.

  • Acadia Pharmaceuticals' Change in Account Payables rose 30599.25% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 6062.62%. This contributed to the annual value of -$1.4 million for FY2024, which is 12816.34% down from last year.
  • As of Q3 2025, Acadia Pharmaceuticals' Change in Account Payables stood at $1.6 million, which was up 30599.25% from $2.0 million recorded in Q2 2025.
  • Acadia Pharmaceuticals' Change in Account Payables' 5-year high stood at $5.2 million during Q4 2023, with a 5-year trough of -$6.5 million in Q3 2023.
  • In the last 5 years, Acadia Pharmaceuticals' Change in Account Payables had a median value of $1.1 million in 2022 and averaged $697578.9.
  • In the last 5 years, Acadia Pharmaceuticals' Change in Account Payables soared by 99325.84% in 2022 and then tumbled by 25216.68% in 2023.
  • Over the past 5 years, Acadia Pharmaceuticals' Change in Account Payables (Quarter) stood at -$846000.0 in 2021, then skyrocketed by 423.64% to $2.7 million in 2022, then soared by 91.12% to $5.2 million in 2023, then tumbled by 155.21% to -$2.9 million in 2024, then soared by 157.11% to $1.6 million in 2025.
  • Its Change in Account Payables stands at $1.6 million for Q3 2025, versus $2.0 million for Q2 2025 and $1.9 million for Q1 2025.